As we approach the 8th Annual Pharma Project and Portfolio Management 2025, the anticipation is palpable. Over the last seven editions, this event has grown into a must-attend for industry leaders, becoming synonymous with high-level discussions.
The 3rd Edition Drug Safety Symposium 2025 – Dubai Chapter, taking place on February 12th –13th, 2025, is set to be an extraordinary event that not only builds on the successes of its previous editions but also introduces something even more exciting
Indian pharmaceutical firms, having gained from favorable sector trends like steady generic pricing and opportunities arising from shortages, alongside stable raw material costs over the last 18-24 months, are expected to advance further in...
Afrezza is the first and sole noninjection insulin created for individuals with both type 1 and type 2 diabetes mellitus. Afrezza, created and produced by MannKind Corporation (MannKind) in the USA, is intended to enhance glycemic control in adult...
The expansion of the global counterfeit drug detection device market is propelled by a compounded annual growth rate (CAGR) of 3.3% in the upcoming ten years, indicating an increased international emphasis on addressing the rising issue of fake...
The market for pharmaceutical manufacturing equipment is expanding quickly due to the increasing demand for pharmaceuticals, particularly generic medications. Generic medications provide a cost-effective substitute for brand-name drugs and have...
The Foreign Direct Investment (FDI) equity into the pharmaceutical industry has shown significant growth in the first half of 2024-25, following a 48 percent drop in fiscal 2023-24 compared to the prior year. The quarter from April to September of...
The global pharmaceutical packaging market is consistently expanding due to the demand for more innovative packaging that improves drug effectiveness while integrating sustainable packaging solutions. The Global Pharmaceutical Packaging Market is...
The Indian pharmaceutical market (IPM) saw an increase of 9.9% in value and 3.1% in volume in November, as per Pharmarack. Following a lackluster volume growth for four months, November emerged as a favorable month for the sector, suggesting an...
The expansion of Indian CDMOs and CROs will accelerate because of the generally positive environment. As per Mordor Intelligence, the contract manufacturing sector is expected to double within the next five years, reaching $44.63 billion...
, CDSCO.jpg)
